David Larsen
Stock Analyst at BTIG
(2.27)
# 3,051
Out of 5,182 analysts
110
Total ratings
43.48%
Success rate
-1.77%
Average return
Main Sectors:
Stocks Rated by David Larsen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HSIC Henry Schein | Initiates: Neutral | n/a | $77.20 | - | 6 | Apr 16, 2026 | |
| BTSG BrightSpring Health Services | Reiterates: Buy | $55 | $48.57 | +13.24% | 7 | Mar 19, 2026 | |
| LFMD LifeMD | Reiterates: Buy | $10 | $4.57 | +118.82% | 5 | Mar 10, 2026 | |
| TOI The Oncology Institute | Reiterates: Buy | $7 | $3.33 | +110.21% | 2 | Mar 9, 2026 | |
| MDLN Medline | Reiterates: Buy | $55 | $45.23 | +21.60% | 2 | Mar 9, 2026 | |
| PGNY Progyny | Maintains: Buy | $35 → $30 | $18.41 | +62.95% | 5 | Mar 5, 2026 | |
| EVH Evolent Health | Maintains: Buy | $10 → $8 | $3.47 | +130.55% | 9 | Feb 25, 2026 | |
| HIMS Hims & Hers Health | Downgrades: Neutral | n/a | $29.39 | - | 4 | Feb 24, 2026 | |
| HQY HealthEquity | Maintains: Buy | $130 → $110 | $83.47 | +31.78% | 6 | Feb 17, 2026 | |
| CCSI Consensus Cloud Solutions | Maintains: Buy | $37 → $40 | $27.11 | +47.55% | 4 | Feb 17, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $80 → $50 | $24.66 | +102.76% | 3 | Feb 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $11 | $7.27 | +51.31% | 3 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $45 → $40 | $34.01 | +17.61% | 3 | Feb 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $14.61 | - | 4 | Dec 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $2.70 | - | 3 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Suspends: Neutral | n/a | $25.32 | - | 2 | Dec 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $340 | $160.45 | +111.90% | 4 | Nov 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $15 | $10.38 | +44.51% | 4 | Sep 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | n/a | $1.37 | - | 4 | Sep 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $290 → $260 | $163.84 | +58.69% | 2 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $7 | $1.01 | +593.07% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $11 → $7 | $0.69 | +917.74% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $37.63 | - | 7 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $35 | $24.41 | +43.38% | 1 | Apr 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $5.85 | - | 3 | Nov 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | n/a | $6.14 | - | 1 | Jan 7, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Market Perform | n/a | $202.34 | - | 6 | Nov 16, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $170 → $160 | $828.32 | -80.68% | 2 | May 29, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $90 → $85 | $78.36 | +8.47% | 3 | Feb 9, 2018 |
Henry Schein
Apr 16, 2026
Initiates: Neutral
Price Target: n/a
Current: $77.20
Upside: -
BrightSpring Health Services
Mar 19, 2026
Reiterates: Buy
Price Target: $55
Current: $48.57
Upside: +13.24%
LifeMD
Mar 10, 2026
Reiterates: Buy
Price Target: $10
Current: $4.57
Upside: +118.82%
The Oncology Institute
Mar 9, 2026
Reiterates: Buy
Price Target: $7
Current: $3.33
Upside: +110.21%
Medline
Mar 9, 2026
Reiterates: Buy
Price Target: $55
Current: $45.23
Upside: +21.60%
Progyny
Mar 5, 2026
Maintains: Buy
Price Target: $35 → $30
Current: $18.41
Upside: +62.95%
Evolent Health
Feb 25, 2026
Maintains: Buy
Price Target: $10 → $8
Current: $3.47
Upside: +130.55%
Hims & Hers Health
Feb 24, 2026
Downgrades: Neutral
Price Target: n/a
Current: $29.39
Upside: -
HealthEquity
Feb 17, 2026
Maintains: Buy
Price Target: $130 → $110
Current: $83.47
Upside: +31.78%
Consensus Cloud Solutions
Feb 17, 2026
Maintains: Buy
Price Target: $37 → $40
Current: $27.11
Upside: +47.55%
Feb 6, 2026
Maintains: Buy
Price Target: $80 → $50
Current: $24.66
Upside: +102.76%
Feb 2, 2026
Maintains: Buy
Price Target: $10 → $11
Current: $7.27
Upside: +51.31%
Feb 2, 2026
Maintains: Buy
Price Target: $45 → $40
Current: $34.01
Upside: +17.61%
Dec 18, 2025
Downgrades: Neutral
Price Target: n/a
Current: $14.61
Upside: -
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $2.70
Upside: -
Dec 12, 2025
Suspends: Neutral
Price Target: n/a
Current: $25.32
Upside: -
Nov 21, 2025
Reiterates: Buy
Price Target: $340
Current: $160.45
Upside: +111.90%
Sep 18, 2025
Maintains: Buy
Price Target: $10 → $15
Current: $10.38
Upside: +44.51%
Sep 5, 2025
Reiterates: Neutral
Price Target: n/a
Current: $1.37
Upside: -
Nov 1, 2024
Maintains: Buy
Price Target: $290 → $260
Current: $163.84
Upside: +58.69%
Sep 17, 2024
Initiates: Buy
Price Target: $7
Current: $1.01
Upside: +593.07%
May 9, 2024
Maintains: Buy
Price Target: $11 → $7
Current: $0.69
Upside: +917.74%
Nov 3, 2023
Downgrades: Neutral
Price Target: n/a
Current: $37.63
Upside: -
Apr 28, 2022
Initiates: Buy
Price Target: $35
Current: $24.41
Upside: +43.38%
Nov 22, 2021
Downgrades: Neutral
Price Target: n/a
Current: $5.85
Upside: -
Jan 7, 2021
Initiates: Neutral
Price Target: n/a
Current: $6.14
Upside: -
Nov 16, 2018
Downgrades: Market Perform
Price Target: n/a
Current: $202.34
Upside: -
May 29, 2018
Maintains: Market Perform
Price Target: $170 → $160
Current: $828.32
Upside: -80.68%
Feb 9, 2018
Maintains: Outperform
Price Target: $90 → $85
Current: $78.36
Upside: +8.47%